Novartis
Also: HHS awards $20 million in telehealth access, infrastructure funds; Lumi launches online service.
Alongside the purchase of Amblyotech, the pharma company announced upcoming collaborations with major video game publisher Ubisoft and McGill University.
The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.
An interview with Timo Heikkilä, cofounder and chief operating officer of Finnish health tech startup Popit.
The announcement was made at the startup event organised in Helsinki, Finland this week.
Also: ActiGraph integrates with Signant Health; AiCure's adherence tool supports Syneos Health's clinical trials.
The acquisition will include Biovotions' wearables, patents, staff, partners and clients.
The pharma's Sandoz division will be handing commercialization of reSET, reSET-O and future therapies back to Pear over the course of a transition period.
Novartis has also announced that it will be opening a new AI innovation lab.
Evergreen Life, GiveVision and Howz are three of the startups joining the new programme.